Literatur
-
1
Cohen P R, Kohn S R, Kurzrock R.
Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome.
Am J Med.
1991;
90
606-613
-
2
Muir E G, Bell A J, Barlow K A.
Multiple primary carcinomata of the colon, duodenum, and larynx associated with keratoacanthomata of the face.
Br J Surg.
1967;
54
191-195
-
3
Torre D.
Multiple sebaceous tumors.
Arch Dermatol.
1968;
98
549-551
-
4
Hall N R, Murday V A, Chapman P. et al .
Genetic linkage in Muir-Torre syndrome to the same chromosomal site as cancer family syndrome.
Eur J Cancer.
1994;
30A
180-182
-
5
Honchel R, Halling K C, Schaid D J. et al .
Microsatellite instability in Muir-Torre syndrome.
Cancer Res.
1994;
54
1159-1163
-
6
Bapat B, Xia L, Madlensky L. et al .
The genetic basis of Muir-Torre syndrome includes the hMLH1 locus.
Am J Hum Genet.
1996;
59
736-739
-
7
Kruse R, Lamberti C, Wang Y. et al .
Is the mismatch repair deficient type of Muir-Torre syndrome confined to mutations in the hMSH2 gene?.
Hum Genet.
1996;
98
747-750
-
8
Kruse R, Rütten A, Lamberti C. et al .
Muir-Torre phenotype has a frequency of DNA mismatch repair-gene-mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria.
Am J Hum Genet.
1998;
63
63-70
-
9
Kolodner R D, Hall N R, Lipford J. et al .
Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for MSH2 mutations.
Genomics.
1994;
24
516-526
-
10
Bitran J, Pellettiere E V.
Multiple sebaceous gland tumors and internal carcinoma: Torre’s syndrome.
Cancer.
1974;
33
835-836
-
11
Schwartz R A, Torre D P.
The Muir-Torre syndrome: a 25-year retrospect.
J Am Acad Dermatol.
1995;
33
90-104
-
12
Ponti G, Losi L, di Gregorio C. et al .
Identification of Mui-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry.
Cancer.
2005;
103
1018-1025
-
13
Yamamoto T, Katayama I, Nishioka , K .
A possible role of interleukin-8 in the induction of psoriasis-like lesions in Torre-Muir Syndrome.
Acta Derm Venereol.
1996;
76
75-77
-
14
Lynch H T, Lynch P M, Pester J. et al .
The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre’s syndrome.
Arch Intern Med.
1981;
141
607-611
-
15
Poleksic S.
Keratoacanthoma and multiple carcinomas.
Br J Dermatol.
1974;
91
461-463
-
16
Mangold E, Pagenstecher C, Leister M. et al .
A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome.
J Med Genet.
2004;
41
567-572
-
17
Mathiak M, Rütten T, Mangold E. et al .
Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 and MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.
Am J Surg Pathol.
2002;
26
338-343
Prof. Dr. med. Josef Rüschoff
Institut für Pathologie
Klinikum Kassel
Mönchebergstr. 41 - 43
34125 Kassel
eMail: ruesch@klinikum-kassel.de
